Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Standards for Plasma and Serum Protoemics in Early Cancer Detection: A Needs Assessment Report From the NIST-NCI SMART Workshop, August 18-19, 2005

Published

Author(s)

Peter E. Barker, Paul D. Wagner, Stephen E. Stein, David M. Bunk, S Srivastava, Gilbert Omenn

Abstract

The National Institute of Standards and Technology (NIST) and the National Cancer Institute (NCI) co-sponsored a workshop on August 18-19, 2005 to examine needs for reference materials to support biomarker discovery for early cancer detection. Needs for plasma and serum proteomics, DNA methylation and specimen reference collections were discussed and recommendations from participants were solicited. This report summarizes the discussion and makes recommendations for serum proteomics reference materials. Summaries of methylation and clinical reference standards will be presented elsewhere.
Citation
Clinical Chemistry
Volume
52
Issue
9

Keywords

biomarkers, cancer, proteomics, reference materials, technology, validation

Citation

Barker, P. , Wagner, P. , Stein, S. , Bunk, D. , Srivastava, S. and Omenn, G. (2006), Standards for Plasma and Serum Protoemics in Early Cancer Detection: A Needs Assessment Report From the NIST-NCI SMART Workshop, August 18-19, 2005, Clinical Chemistry (Accessed December 7, 2024)

Issues

If you have any questions about this publication or are having problems accessing it, please contact reflib@nist.gov.

Created September 1, 2006, Updated February 19, 2017